S
Seung-Mo Hong
Researcher at University of Ulsan
Publications - 383
Citations - 21628
Seung-Mo Hong is an academic researcher from University of Ulsan. The author has contributed to research in topics: Pancreatic cancer & Cancer. The author has an hindex of 53, co-authored 361 publications receiving 17907 citations. Previous affiliations of Seung-Mo Hong include University of Virginia Health System & Johns Hopkins University School of Medicine.
Papers
More filters
Journal ArticleDOI
Endoscopic ultrasound-guided fine-needle aspiration can target right liver mass.
Dongwook Oh,Dong Wan Seo,Seung-Mo Hong,Tae Jun Song,Do Hyun Park,Sang Soo Lee,Sung Koo Lee,Myung-Hwan Kim +7 more
TL;DR: EUS-FNA can be a safe and efficient method for the diagnosis of liver mass and it is technically feasible even for those in the right lobe, and no complications developed after procedure.
Journal ArticleDOI
Precursor Lesions of Pancreatic Cancer.
Joo Young Kim,Seung-Mo Hong +1 more
TL;DR: Recent updates regarding histopathological and molecular pathological overviews of PDAC precursor lesions are discussed and better understanding of such lesions may contribute to earlier detection ofPDAC or its precursor lesions and improve PDAC patient survival.
Journal ArticleDOI
Amsterdam International Consensus Meeting: tumor response scoring in the pathology assessment of resected pancreatic cancer after neoadjuvant therapy
Boris V. Janssen,Faik Tutucu,Faik Tutucu,Stijn van Roessel,Volkan Adsay,Olca Basturk,Fiona Campbell,Claudio Doglioni,Irene Esposito,Roger Feakins,Noriyoshi Fukushima,Anthony J. Gill,Ralph H. Hruban,Jeffrey B. Kaplan,Bas Groot Koerkamp,Seung-Mo Hong,Alyssa M. Krasinskas,Claudio Luchini,Johan Offerhaus,Arantza Farina Sarasqueta,Chanjuan Shi,Aatur D. Singhi,Thomas F. Stoop,Thomas F. Stoop,Eline C. Soer,Elizabeth D. Thompson,Geertjan van Tienhoven,Marie-Louise F. van Velthuysen,Johanna W. Wilmink,Marc G. Besselink,Lodewijk A.A. Brosens,Huamin Wang,Caroline S. Verbeke,Joanne Verheij +33 more
TL;DR: An international consensus meeting on TRS took place in November 2019 in Amsterdam, The Netherlands, and an overview of the outcomes and consensus statements that originated from this meeting are provided.
Journal ArticleDOI
HER3 overexpression is a prognostic indicator of extrahepatic cholangiocarcinoma
TL;DR: The role of HER2 and HER3 in extrahepatic cholangiocarcinoma (EHCC) was studied in 230 EHCC cases using a tissue microarray and compared with clinicopathological variables, including the survival of patients.
Journal ArticleDOI
Clinicopathological characteristics of intraductal papillary neoplasm of the bile duct: a Japan-Korea collaborative study
Keiichi Kubota,Jin-Young Jang,Yasuni Nakanuma,Kee Taek Jang,Yasuo Haruyama,Noriyoshi Fukushima,Toru Furukawa,Seung-Mo Hong,Yuhki Sakuraoka,Haeryoung Kim,Takatsugu Matsumoto,Kyung Bun Lee,Yoh Zen,Jaeri Kim,Masaru Miyazaki,Dong Wook Choi,Jin Seok Heo,Itaru Endo,Shin Hwang,Masafumi Nakamura,Ho-Seong Han,Shinji Uemoto,Sang-Jae Park,Eun Kyung Hong,Atsushi Nanashima,Dong-Sik Kim,Joo Young Kim,Tetsuo Ohta,Koo Jeong Kang,Takumi Fukumoto,Yang Won Nah,Hyung Il Seo,Kazuo Inui,Dong Sup Yoon,Michiaki Unno +34 more
TL;DR: The prevalent location and incidence of intraductal papillary neoplasm of the bile duct and invasive carcinoma associated with them have varied markedly among studies due to differences in diagnostic criteria and tumor location.